Meeting on the Mesa 2026 has ended. This guide stays up as the record of who was there. Next: Meeting on the Mesa 2027, Oct 18–20, 2027 in Phoenix

Investors at Meeting on the Mesa 2026

Oct 5–7, 2026 Phoenix, AZ ~1.5k attendees Website

46 investors are at Meeting on the Mesa 2026 — 7 presentations on the program. Most represented: OrbiMed (2 on the program), Delin Ventures (1 on the program), Gordon MD Global Investments (1 on the program). 8 of them have their own page in this guide. As of Oct 6, 2026.

All 592 organizations at Meeting on the Mesa 2026 →

Focus area
Top represented
Showing 1–19 of 46 organizations
OrganizationMeeting on the Mesa 2026 Attendance
◆Gold Sponsor
InvestorsGold Sponsor
Invests in and operates businesses across healthcare, pharmaceuticals, infrastructure, finance, and other industries.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
OrbiMed
New York, NY
Investors
Invests in healthcare and life sciences companies through venture capital, private equity, public equity, and royalty financing.
Chair
Mon, Oct 5
11:45am
Patient Spotlight: a Metachromatic Leukodystrophy Advocate
Delin Ventures
London, United Kingdom
Investors
Invests in and builds early-stage cell therapy companies and related life-sciences infrastructure, alongside technology startups.
Investors
Manages private and public funds investing in biopharmaceutical companies across the United States, Europe and Japan.
Jennison
New York, NY
Investors
Investment manager offering active equity and fixed-income strategies to institutional clients.
Novo Holdings
Copenhagen, Denmark
Investors
Invests in life science companies and manages the Novo Nordisk Foundation’s assets across public and private markets.
Attendee
Samsara Biocapital
Palo Alto, CA
Investors
Invests in biotechnology companies developing transformative therapeutics.
28 Capital
Boston, MA
Investors
Life sciences venture fund that forms and invests in early-stage biotech and therapeutic companies.
Attending
On the meeting’s published attendee list
4BIO Capital
London, United Kingdom
Investors
Venture capital firm investing in early-stage companies developing cell, gene, RNA and other advanced therapies.
Attending
On the meeting’s published attendee list
6C
683 Capital
New York, NY
Investors
Investment manager running pooled funds and taking positions in publicly traded companies, including biotechnology firms.
Attending
On the meeting’s published attendee list
AO
Alpha Omega Investment & Development
Attending
On the meeting’s published attendee list
Altaris
New York, NY
Investors
Healthcare investment firm that acquires and builds companies across healthcare subsectors.
Attending
On the meeting’s published attendee list
Altius Bioventures Capital
North Vancouver, Canada
Investors
Invests in and co-builds early-stage companies developing tools and technologies for advanced therapy manufacturing, testing and logistics.
Attending
On the meeting’s published attendee list
Investors
Invests in and helps build early-stage life science and technology companies from scientific discoveries.
Attending
On the meeting’s published attendee list
Avant Bio
New York, NY
Investors
Invests in life science, healthtech and therapeutic-enabling technology companies.
Attending
On the meeting’s published attendee list
Avego Management
Alpharetta, GA
Investors
Invests in healthcare and biotech companies through growth capital and other investment strategies.
Attending
On the meeting’s published attendee list
Investors
Multi-strategy asset manager investing across public and private markets for institutional and other investors.
Attending
On the meeting’s published attendee list
BroadOak
Washington, DC
Investors
Invests growth capital and provides investment banking services to life sciences tools, diagnostics, and biopharma services companies.
Attending
On the meeting’s published attendee list
Canaccord Genuity
Toronto, Canada
Investors
Provides investment banking, M&A advisory, equity research, and sales and trading services to corporate and institutional clients.
Attending
On the meeting’s published attendee list

Explore the full Meeting on the Mesa 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full Meeting on the Mesa 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from investors

Tell us what you sell and we’ll find the people at these investors most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse Meeting on the Mesa 2026 by

Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction